MoneyWorks4Me

Sandu Pharmaceuticals informs about issuance of duplicate certificate

04 Sep 2021 Evaluate

Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Sandu Pharmaceuticals has informed that Linkintime India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares for Shareholder, Sushila Agarwal (Folio No: S01103), further details attached.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..